Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow Reinvestment Rate
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Reinvestment Rate of 0.64x as of September 2025, reinvesting CN¥128.94 Million (capex CN¥128.94 Million ) from operating cash flow of CN¥201.83 Million. Check Jiangsu Kanion Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2024)
Historical reinvestment intensity for Jiangsu Kanion Pharmaceutical Co Ltd across 23 annual periods. Explore 600557 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year capital reinvestment analysis for Jiangsu Kanion Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Jiangsu Kanion Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.31x | CN¥919.25 Million | CN¥702.49 Million | CN¥476.69 Million | ▲ +51.9% |
| 2023 | 0.86x | CN¥837.79 Million | CN¥972.32 Million | CN¥297.48 Million | ▲ +269.6% |
| 2022 | 0.23x | CN¥232.16 Million | CN¥995.94 Million | CN¥211.09 Million | ▼ -35.8% |
| 2021 | 0.36x | CN¥330.02 Million | CN¥908.30 Million | CN¥171.52 Million | ▼ -12.1% |
| 2020 | 0.41x | CN¥289.74 Million | CN¥701.10 Million | CN¥190.32 Million | ▼ -22.1% |
| 2019 | 0.53x | CN¥491.24 Million | CN¥925.73 Million | CN¥490.06 Million | ▲ +3.6% |
| 2018 | 0.51x | CN¥325.92 Million | CN¥636.39 Million | CN¥315.73 Million | ▼ -49.5% |
| 2017 | 1.01x | CN¥388.01 Million | CN¥382.93 Million | CN¥260.94 Million | ▼ -10.0% |
| 2016 | 1.13x | CN¥336.59 Million | CN¥299.02 Million | CN¥325.24 Million | ▲ +50.1% |
| 2015 | 0.75x | CN¥386.09 Million | CN¥514.80 Million | CN¥374.80 Million | ▼ -24.5% |
| 2014 | 0.99x | CN¥309.36 Million | CN¥311.54 Million | CN¥309.36 Million | ▲ +13.6% |
| 2013 | 0.87x | CN¥339.23 Million | CN¥388.11 Million | CN¥339.23 Million | ▼ -27.0% |
| 2012 | 1.20x | CN¥253.88 Million | CN¥212.11 Million | CN¥253.88 Million | ▼ -63.2% |
| 2011 | 3.25x | CN¥293.53 Million | CN¥90.19 Million | CN¥293.53 Million | ▲ +90.1% |
| 2010 | 1.71x | CN¥284.89 Million | CN¥166.40 Million | CN¥284.89 Million | ▲ +15.3% |
| 2008 | 1.48x | CN¥86.69 Million | CN¥58.39 Million | CN¥86.69 Million | ▲ +133.8% |
| 2007 | 0.63x | CN¥58.88 Million | CN¥92.73 Million | CN¥58.88 Million | ▲ +182.2% |
| 2006 | 0.22x | CN¥24.52 Million | CN¥108.98 Million | CN¥24.52 Million | ▼ -57.3% |
| 2005 | 0.53x | CN¥53.39 Million | CN¥101.44 Million | CN¥53.39 Million | ▼ -90.7% |
| 2004 | 5.66x | CN¥122.68 Million | CN¥21.68 Million | CN¥122.68 Million | ▼ -23.5% |
| 2003 | 7.40x | CN¥126.72 Million | CN¥17.13 Million | CN¥126.72 Million | ▼ -6.3% |
| 2002 | 7.90x | CN¥88.07 Million | CN¥11.15 Million | CN¥88.07 Million | ▲ +800.5% |
| 2001 | 0.88x | CN¥18.43 Million | CN¥21.02 Million | CN¥18.43 Million | — |